| - Industry | - Sector | Mr. Hoyoung Yun Ph.D. CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Curiosis Inc. is a prominent biotechnology firm dedicated to the development, manufacture, and supply of cutting-edge life science instruments. With an emphasis on laboratory automation, the company's innovative solutions cater primarily to cell-based applications, live cell imaging, and automated cell analysis, ensuring enhanced efficiency in experimental practices. Known for its high-quality production and stringent quality management, Curiosis operates an in-house system that maintains exceptional standards in manufacturing processes. The company collaborates closely with academic institutions, medical research centers, and industry partners, providing essential support in areas such as tissue engineering, single cell analysis, microfluidics, and molecular diagnostics. By globally distributing its advanced technologies and earning accolades for innovation, Curiosis significantly contributes to the advancement of scientific capabilities and the productivity of laboratories throughout Asia, Europe, and North America.
The Celloger is an advanced life science instrument designed for automated cell culture and analysis. This product enables researchers to streamline their workflow by minimizing human intervention, thereby increasing throughput and ensuring reproducible results. The integration of real-time monitoring provides users with valuable insights into cellular behavior and responses.
The FACSCOPE series encompasses a range of automated flow cytometry solutions that facilitate precise and quantitative analysis of cells. Its user-friendly interface and robust performance make it an invaluable tool for researchers, offering capabilities such as multi-parameter analysis and high-speed data acquisition, which are essential for various biomedical applications.
Curiosis offers comprehensive laboratory automation solutions tailored to enhance operational efficiency. These solutions encompass customized automated workflows that integrate various laboratory processes, facilitating rapid sample processing and data collection, which are critical for advancing research methodologies.
These state-of-the-art imaging systems allow researchers to observe live cells in real-time, providing critical information about cell dynamics, morphology, and interactions. By employing cutting-edge imaging technologies, Curiosis enables scientists to gather significant data that informs their studies.
Curiosis's single cell analysis technologies empower researchers to investigate the heterogeneity of cellular populations at an unparalleled resolution. These tools are essential for understanding complex biological systems and paving the way for breakthroughs in personalized medicine and therapeutic interventions.
Microfluidics solutions from Curiosis enable the precise manipulation and analysis of small fluid volumes, facilitating high-throughput experimentation and significant cost savings. These technologies are vital for applications in diagnostics, drug development, and fundamental research.
Curiosis provides innovative products and services for molecular diagnostics that enhance the accuracy and efficiency of testing protocols in clinical and research settings. These diagnostic solutions are crucial for detecting diseases at an early stage and for understanding complex genetic conditions.